AU2529388A – Method of reducing glial scar formation and promoting axon growth
– Google Patents
AU2529388A – Method of reducing glial scar formation and promoting axon growth
– Google Patents
Method of reducing glial scar formation and promoting axon growth
Info
Publication number
AU2529388A
AU2529388A
AU25293/88A
AU2529388A
AU2529388A
AU 2529388 A
AU2529388 A
AU 2529388A
AU 25293/88 A
AU25293/88 A
AU 25293/88A
AU 2529388 A
AU2529388 A
AU 2529388A
AU 2529388 A
AU2529388 A
AU 2529388A
Authority
AU
Australia
Prior art keywords
scar formation
axon growth
glial scar
promoting axon
reducing glial
Prior art date
1987-09-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25293/88A
Inventor
James W. Jacobberger
Jerry Silver
George M. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Case Western Reserve University
Original Assignee
Case Western Reserve University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1987-09-11
Filing date
1988-09-09
Publication date
1989-04-17
1988-09-09
Application filed by Case Western Reserve University
filed
Critical
Case Western Reserve University
1989-04-17
Publication of AU2529388A
publication
Critical
patent/AU2529388A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
C12N5/06—Animal cells or tissues; Human cells or tissues
C12N5/0602—Vertebrate cells
C12N5/0618—Cells of the nervous system
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2510/00—Genetically modified cells
AU25293/88A
1987-09-11
1988-09-09
Method of reducing glial scar formation and promoting axon growth
Abandoned
AU2529388A
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US07/096,373
US4900553A
(en)
1987-09-11
1987-09-11
Method of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes
US096373
1987-09-11
Publications (1)
Publication Number
Publication Date
AU2529388A
true
AU2529388A
(en)
1989-04-17
Family
ID=22257064
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU25293/88A
Abandoned
AU2529388A
(en)
1987-09-11
1988-09-09
Method of reducing glial scar formation and promoting axon growth
Country Status (7)
Country
Link
US
(1)
US4900553A
(en)
EP
(1)
EP0332692A4
(en)
JP
(1)
JPH02501535A
(en)
KR
(1)
KR890701725A
(en)
AU
(1)
AU2529388A
(en)
IL
(1)
IL87738A0
(en)
WO
(1)
WO1989002459A1
(en)
Families Citing this family (33)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US5871996A
(en)
1994-02-04
1999-02-16
Bio Merieux
Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis
DK0554352T3
(en)
*
1990-10-19
2003-06-10
Univ New York
Method of Transplanting Cells into the Brain and Therapeutic Uses thereof.
US5618531A
(en)
*
1990-10-19
1997-04-08
New York University
Method for increasing the viability of cells which are administered to the brain or spinal cord
CA2128630A1
(en)
*
1992-01-23
1993-08-05
Bruce D. Cherksey
A method for transplanting cells into the brain and therapeutic uses therefor
FR2689521B1
(en)
*
1992-04-03
1996-07-19
Bio Merieux
PROCESS FOR OBTAINING AND MAINTAINING A SUSTAINABLE CELL CULTURE INFECTED WITH A VIRUS ASSOCIATED WITH MULTIPLE SCLEROSIS, AND BIOLOGICALS DERIVED FROM SAID CULTURE.
FR2689520B1
(en)
1992-04-03
1996-07-19
Bio Merieux
METHOD AND CULTURE MEDIUM FOR OBTAINING CELLS INFECTED WITH A VIRUS ASSOCIATED WITH MULTIPLE SCLEROSIS.
DE69408373T2
(en)
*
1993-06-01
1998-07-16
Ono Pharmaceutical Co
Pentanoic acid derivatives
FR2716198B1
(en)
*
1994-02-15
1996-04-19
Bio Merieux
Cytotoxic factor as associated with multiple sclerosis, its detection and quantification.
AU2640595A
(en)
*
1994-05-17
1995-12-05
Rutgers University
Immortalized and transformed astrocyte-derived cells
FR2737500B1
(en)
1995-08-03
1997-08-29
Bio Merieux
VIRAL MATERIAL AND NUCLEOTIDE FRAGMENTS ASSOCIATED WITH MULTIPLE SCLEROSIS, FOR DIAGNOSIS, PROPHYLACTICS AND THERAPEUTICS
DE69739544D1
(en)
*
1996-11-26
2009-10-01
Bio Merieux
VIRAL MATERIALS AND MULTIPLE SCLEROSIS ASSOCIATED NUCLEOTIDE FRAGMENTS WITH DIAGNOSTIC, PROPHYLACTIC AND THERAPEUTIC USES
US8734718B2
(en)
*
2007-08-17
2014-05-27
The Invention Science Fund I, Llc
Systems, devices, and methods including catheters having an actively controllable therapeutic agent delivery component
US20090048648A1
(en)
*
2007-08-17
2009-02-19
Searete Llc, A Limited Liability Corporation Of The State Of Delaware
Self-sterilizing device
US20110160644A1
(en)
*
2007-08-17
2011-06-30
Searete Llc, A Limited Liability Corporation Of The State Of Delaware
Systems, devices, and methods including catheters configured to release ultraviolet energy absorbing agents
US8706211B2
(en)
*
2007-08-17
2014-04-22
The Invention Science Fund I, Llc
Systems, devices, and methods including catheters having self-cleaning surfaces
US8753304B2
(en)
*
2007-08-17
2014-06-17
The Invention Science Fund I, Llc
Systems, devices, and methods including catheters having acoustically actuatable waveguide components for delivering a sterilizing stimulus to a region proximate a surface of the catheter
US8460229B2
(en)
*
2007-08-17
2013-06-11
The Invention Science Fund I, Llc
Systems, devices, and methods including catheters having components that are actively controllable between transmissive and reflective states
US8702640B2
(en)
*
2007-08-17
2014-04-22
The Invention Science Fund I, Llc
System, devices, and methods including catheters configured to monitor and inhibit biofilm formation
US8647292B2
(en)
*
2007-08-17
2014-02-11
The Invention Science Fund I, Llc
Systems, devices, and methods including catheters having components that are actively controllable between two or more wettability states
US8366652B2
(en)
*
2007-08-17
2013-02-05
The Invention Science Fund I, Llc
Systems, devices, and methods including infection-fighting and monitoring shunts
US20090163964A1
(en)
*
2007-08-17
2009-06-25
Searete Llc, A Limited Liability Corporation Of The State Of Delaware
System, devices, and methods including sterilizing excitation delivery implants with general controllers and onboard power
US20090177254A1
(en)
*
2007-08-17
2009-07-09
Searete Llc, A Limited Liability Of The State Of The State Of Delaware
System, devices, and methods including actively-controllable electrostatic and electromagnetic sterilizing excitation delivery system
US20090163977A1
(en)
*
2007-08-17
2009-06-25
Searete Llc, A Limited Liability Corporation Of The State Of Delaware
System, devices, and methods including sterilizing excitation delivery implants with cryptographic logic components
US20110208023A1
(en)
*
2008-12-04
2011-08-25
Goodall Eleanor V
Systems, devices, and methods including implantable devices with anti-microbial properties
WO2010065135A1
(en)
*
2008-12-04
2010-06-10
Searete, Llc
System, devices, and methods including actively-controllable sterilizing excitation delivery implants
US20110208021A1
(en)
*
2008-12-04
2011-08-25
Goodall Eleanor V
Systems, devices, and methods including implantable devices with anti-microbial properties
US20110295088A1
(en)
2008-12-04
2011-12-01
Searete Llc, A Limited Liability Corporation Of The State Of Delaware
Systems, devices, and methods including implantable devices with anti-microbial properties
US20110152751A1
(en)
*
2008-12-04
2011-06-23
Searete Llc, A Limited Liability Corporation Of The State Of Delaware
Systems, devices, and methods including catheters having UV-Energy emitting coatings
US20110208026A1
(en)
*
2008-12-04
2011-08-25
Goodall Eleanor V
Systems, devices, and methods including implantable devices with anti-microbial properties
US8585627B2
(en)
*
2008-12-04
2013-11-19
The Invention Science Fund I, Llc
Systems, devices, and methods including catheters configured to monitor biofilm formation having biofilm spectral information configured as a data structure
US20110160681A1
(en)
*
2008-12-04
2011-06-30
Searete Llc, A Limited Liability Corporation Of The State Of Delaware
Systems, devices, and methods including catheters having light removable coatings based on a sensed condition
JP5606713B2
(en)
*
2009-09-28
2014-10-15
オリンパス株式会社
Method for stimulating and / or measuring central nerve and probe therefor
EP2694644B1
(en)
2011-03-30
2018-01-24
Cellular Dynamics International, Inc.
Priming of pluripotent stem cells for neural differentiation
Family Cites Families (8)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4378344A
(en)
*
1979-09-28
1983-03-29
Ventrex Laboratories, Inc.
Method and apparatus for performing multiple, simultaneous in vitro diagnostic tests using a solid phase system
US4376071A
(en)
*
1980-08-21
1983-03-08
Research Corporation
Mitogenic spinal cord growth factor
US4532134A
(en)
*
1981-04-06
1985-07-30
Malette William Graham
Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
US4388309A
(en)
*
1981-06-10
1983-06-14
Shanksville Corporation, N.V.
Process for suppressing graft rejection in organ transplantation
US4642291A
(en)
*
1982-09-01
1987-02-10
Sloan-Kettering Institute For Cancer Research
Cell surface antigens of human astrocytoma
US4574116A
(en)
*
1983-01-13
1986-03-04
The Board Of Trustees Of The Leland Stanford Jr. University
Methods and cell lines for immortalization and monoclonal antibody production by antigen-stimulated B-lymphocytes
US4662884A
(en)
*
1984-04-25
1987-05-05
University Of Utah Research Foundation
Prostheses and methods for promoting nerve regeneration
US4707448A
(en)
*
1984-10-04
1987-11-17
The United States Of America As Represented By The Department Of Health And Human Services
Immortal line of human fetal glial cells
1987
1987-09-11
US
US07/096,373
patent/US4900553A/en
not_active
Expired – Lifetime
1988
1988-09-09
EP
EP19880908785
patent/EP0332692A4/en
not_active
Withdrawn
1988-09-09
JP
JP63507996A
patent/JPH02501535A/en
active
Pending
1988-09-09
AU
AU25293/88A
patent/AU2529388A/en
not_active
Abandoned
1988-09-09
WO
PCT/US1988/003115
patent/WO1989002459A1/en
not_active
Application Discontinuation
1988-09-11
IL
IL87738A
patent/IL87738A0/en
unknown
1989
1989-05-11
KR
KR1019890700830A
patent/KR890701725A/en
not_active
Application Discontinuation
Also Published As
Publication number
Publication date
WO1989002459A1
(en)
1989-03-23
EP0332692A4
(en)
1990-09-12
JPH02501535A
(en)
1990-05-31
IL87738A0
(en)
1989-02-28
US4900553A
(en)
1990-02-13
KR890701725A
(en)
1989-12-21
EP0332692A1
(en)
1989-09-20
Similar Documents
Publication
Publication Date
Title
AU2529388A
(en)
1989-04-17
Method of reducing glial scar formation and promoting axon growth
AU631541B2
(en)
1992-12-03
Hydroprocessing catalyst and method of preparation
AU2378088A
(en)
1989-05-04
Tag and method of making same
AU584469B2
(en)
1989-05-25
Lightweight nonwoven tissue and method of manufacture
AU2422088A
(en)
1989-02-13
Composite fastener and method of manufacture
GB2202698B
(en)
1991-12-11
Microfuse and method of manufacture
AU603967B2
(en)
1990-11-29
Triazone fertilizer and method of making
AU4683589A
(en)
1991-06-21
Cloning and expression of transforming growth factor beta-2
AU2531988A
(en)
1989-03-09
Electromagnet and method of forming same
AU3084789A
(en)
1989-10-05
Lattice and method of making same
AU587764B2
(en)
1989-08-24
Hasp-type latch and method of making and using same
AU7864387A
(en)
1988-03-31
Tag and method of making
AU1185488A
(en)
1988-08-10
Production of fibroblast growth factor
AU3192389A
(en)
1989-09-06
Novel diazines and their method of preparation
AU1847888A
(en)
1989-01-05
Method of making a prosthetic component and component made according to the method
AU4981390A
(en)
1990-08-23
Handbrush and method of manufacture thereof
AU2200488A
(en)
1989-03-23
Salbutamol-containing plaster and method of producing same
AU3270589A
(en)
1989-12-07
Antiperspirant and method of making same
AU2593188A
(en)
1989-06-01
Iminophenylthiazolidines, process of preparation and method of use
AU1076588A
(en)
1988-07-28
Implant material and method of producing the same
AU1792188A
(en)
1988-12-21
Toy figure and method of using same
AU2553988A
(en)
1989-05-23
Method of making artificial snow
IL87264A0
(en)
1988-12-30
Artificial skin and method for its production
GB2210620B
(en)
1992-07-08
Cloning and expression of transforming growth factor ¼2
AU2345188A
(en)
1989-04-06
Cloning and expression of transforming growth factor 2b
None